Sign up to save your podcasts
Or
Share A Very Meh-Ry Biotech Year and What’s Ahead in 2025
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A Very Meh-Ry Biotech Year and What’s Ahead in 2025
We continue our holiday tradition by welcoming STAT News Senior Biotech Writer Adam Feuerstein for our annual look back at the year that was in biotech and what’s ahead for the industry with the JPMorgan Healthcare conference and beyond in 2025. Feuerstein offers his view on finance and dealmaking in 2024, new drug approvals, and his annual take on the best and worst CEOs of the year. We also discuss what Trump 2.0 may look like for the industry, changes coming to the FDA and other agencies, and what hot technologies to watch in the year ahead.
View all episodes
By Levine Media Group
3.7
3939 ratings
We continue our holiday tradition by welcoming STAT News Senior Biotech Writer Adam Feuerstein for our annual look back at the year that was in biotech and what’s ahead for the industry with the JPMorgan Healthcare conference and beyond in 2025. Feuerstein offers his view on finance and dealmaking in 2024, new drug approvals, and his annual take on the best and worst CEOs of the year. We also discuss what Trump 2.0 may look like for the industry, changes coming to the FDA and other agencies, and what hot technologies to watch in the year ahead.
More shows like The Bio Report
View all
On Being with Krista Tippett
10,389 Listeners
The Long Run with Luke Timmerman
122 Listeners
The Atlantic Interview
1,924 Listeners
Worklife with Adam Grant
9,187 Listeners
The Readout Loud
317 Listeners
Interesting Times with Ross Douthat
6,751 Listeners
Biotech 2050 Podcast
59 Listeners
Business Of Biotech
88 Listeners
BioCentury This Week
29 Listeners
Raising Health
147 Listeners
The World as You’ll Know It: The Future Of Aging
108 Listeners
The Ezra Klein Show
15,220 Listeners
Biotech Hangout
10 Listeners
Ground Truths
51 Listeners
The New York Times Narrated
36 Listeners